Molecular and Clinical Characterization of ۷ Iranian Patients with Severe Congenital Factor V Deficiency: Identification of ۴ Novel Mutations

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 154

This Paper With 13 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JIML-9-1_005

تاریخ نمایه سازی: 3 اسفند 1401

Abstract:

Background and Aims: Congenital factor V (FV) deficiency is a rare bleeding disorder with ۱ in ۱۰۰۰۰۰۰ persons in the general population. Individuals with FV activity <۱% and very low FV antigen levels are characterized as severe FV deficient patients. Little data is available about the molecular basis of this bleeding disorder in Iran. Materials and Methods: We analyzed ۷ unrelated Iranian FV deficient patients regarding clinical manifestation and genotype. The molecular dynamic simulation was carried out to analyze the effect of novel mutations on the FV structure.   Results: All cases had recurrence epistaxis, oral cavity bleeding, and hematoma were frequent in our patients. The molecular analysis led to the identification of three already reported mutations (IVS ۱۹+۳ A>T, ۴۰۱۴-۴۰۱۷ del TCAG and p.P۴۱۹R) and four novel mutations (IVS۹-۱ G>C, Y۴۷۸D, L۱۸۴۴P, I۱۵۵۶T) in the FV gene of our patients. According to the molecular modeling results, it seems that in the two mutations Y۴۷۸D and I۱۵۵۶T, an increased number of H-bonds in mutant proteins compared to natural ones reduces the flexibility and increases the stability of the mutant proteins. The results also show that in L۱۸۴۴P and I۱۵۵۶T mutations, the total solvent accessible surface area (both hydrophilic and hydrophobic) significantly decreases compared to the natural variants.    Conclusion: Identifying the causative mutation in patients with FV deficiency helps to determine the molecular basis of this bleeding disorder and gain more insight into explaining the variable clinical manifestations of patients with FV deficiency.

Authors

صدیقه ستاری

Department of Hematology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

محمود شمس

Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska, Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden

شادی طبیبیان

Department of Hematology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

فرهاد ذاکر

Department of Hematology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

محمد رضا رضوانی

Department of Hematology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Dahlbäck B. Blood coagulation. Lancet ۲۰۰۰; ۳۵۵(۹۲۱۵): ۱۶۲۷-۶۳۲ ...
  • . Mann KG, Kalafatis M. Factor V: A combination of ...
  • . Milstone J. Thrombokinase as prime activator of prothrombin: historical ...
  • . Suzuki K, Dahlbäck B, Stenflo J. Thrombin-catalyzed activation of ...
  • . Nesheim M, Foster WB, Hewick R, Mann K. Characterization ...
  • . Kane WH, Ichinose A, Hagen FS, Davie EW. Cloning ...
  • . van Wijk R, Nieuwenhuis K, van den Berg M, ...
  • . Jenny R, Tracy P, Mann K. The physiology and ...
  • . Tuddenham E, Giannelli F. In Bloom, AL, Forbes, CD, ...
  • . Tuddenham EG, Cooper DN. The molecular genetics of haemostasis ...
  • . Rosing J, Tans G. Coagulation factor V: an old ...
  • . Tabibian S, Shiravand Y, Shams M, Safa M, Gholami ...
  • . Duga S, Asselta R, Tenchini ML. Coagulation factor V. ...
  • . Orfeo T, Brufatto N, Nesheim ME, Xu H, Butenas ...
  • . Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape ...
  • . Cripe LD, Moore KD, Kane WH. Structure of the ...
  • . Asselta R, Peyvandi F. Factor V deficiency. Semin Thromb ...
  • . Owren P. Parahaemophilia: haemorrhagic diathesis due to absence of ...
  • . Huang J, Koerper M. Factor V deficiency: a concise ...
  • . Lak M, Sharifian R, Peyvandi F, Mannucci P. Symptoms ...
  • . Chingale A, Eisenhut M, Gadiraju A, Liesner R. A ...
  • . Özkaya H, Akcan AB, Aydemir G, Akcan M, Kul ...
  • . Shinozawa K, Amano K, Suzuki T, Tanaka A, Iijima ...
  • . Page S, Guest E, Wicklund B, Andrews W, Daniel ...
  • . Thalji N, Camire RM. Parahemophilia: New insights into factor ...
  • . Van Wijk R, Montefusco MC, Duga S, Asselta R, ...
  • . Asselta R, Montefusco M, Duga S, Malcovati M, Peyvandi ...
  • . Guasch JF, Cannegieter S, Reitsma PH, Van't Veer‐Korthof ET, ...
  • . Borhany M, Ranc A, Fretigny M, Moulis G, Abid ...
  • . Paraboschi EM, Menegatti M, Rimoldi V, Borhany M, Abdelwahab ...
  • . Sedano-Balbás S, Lyons M, Cleary B, Murray M, Gaffney ...
  • . Soria J, Blangero J, Souto J, Martínez-Sánchez E, Martínez-Marchán ...
  • . Cui J, O’Shea KS, Purkayastha A, Saunders TL, Ginsburg ...
  • . Steen Mr, Miteva M, Villoutreix BO, Yamazaki T, Dahlbäck ...
  • . Vos H. Inherited defects of coagulation factor V: the ...
  • . Schrijver I HKR, Jones CD, Garcia KC, Zehnder JL. ...
  • . Nuzzo F, Bulato C, Nielsen B, Lee K, Wielders ...
  • . Schrijver I, Koerper MA, Jones CD, Zehnder JL. Homozygous ...
  • . Castoldi E, Lunghi B, Mingozzi F, Muleo G, Redaelli ...
  • نمایش کامل مراجع